ClinicalTrials.Veeva

Menu

Study to Assess the Longterm Safety of Sildenafil Citrate in Patients With Pulmonary Arterial Hypertension

Viatris logo

Viatris

Status and phase

Completed
Phase 3

Conditions

Pulmonary Hypertension

Treatments

Drug: Sildenafil citrate

Study type

Interventional

Funder types

Industry

Identifiers

NCT00159887
A1481142

Details and patient eligibility

About

Open label extension study to the pivotal efficacy study to assess the safety of sildenafil citrate in patients with pulmonary arterial hypertension

Enrollment

260 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with PAH who had completed the 12 week pivotal study

Exclusion criteria

  • Any other patients with PAH that had not been included into the pivotal study

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

65

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems